Statistics

Total Visits

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)76

Select a period of time:

Number of views in the range

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)25

Views

Views
October 20256
November 20257
December 20252
January 20262
February 20261
March 20267
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
United Kingdom3
Brazil3
Peru2
France2
Argentina1
Morocco1
Venezuela1
South Africa1
 

Top cities views

Views
Lyon2
San Jose2
Lima2
Ashburn1
Barquisimeto1
Cape Town1
Casablanca1
London1
Memphis1
Palhoça1